Why is "ARCH Venture Partners" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-29 11:55:45
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
ARCH_Venture_Partners entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-29 and was most recently seen on 2026-03-29.
Wikipedia Overview
ARCH Venture Management LLC is an American venture capital firm based in Chicago. The firm mainly invests in companies from the biotechnology industry but has also invested other industries such as semiconductors and technology.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Metsera backers establish new biotech armed with China-licensed immunology asset - pharmaceutical-technology.com
-
Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners - TradingView
-
Trase Raises $107 Million Seed Round Led By ARCH Venture Partners - pulse2.com
-
Trase Raises $107M Seed Round Led by ARCH Venture Partners to Continue Building Agentic Operating System for Regulated Industries - businesswire.com
-
Haisco enters into Exclusive License Agreement with new US venture founded by Population Health Partners and ARCH Venture Partners - The Manila Times
-
Moleculent launches with $26 million Series A financing to advance the spatial mapping of cell-cell communication - Arctic Today
-
Syndex Bio secures £11.5 million Seed investment led by ARCH Venture Partners - UK Tech Investment News
-
ARCH Venture Partners Announces New Fund to Create the Next Generation of Biotech Companies - PR Newswire
-
ARCH Venture Partners raises $3 billion for a new biotech fund - STAT
-
A top biotech venture capitalist said he saw the pandemic coming. He shared his prediction for how the coronavirus will shape 2021. - Business Insider
-
Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science - BioPharma Dive
-
Chicago’s biggest biotech investor is raising another $3 billion fund - Crain's Chicago Business
-
Arch closes $3B-plus fund as biotech investment environment shows more signs of a revival - Fierce Biotech
-
Bob Nelsen of ARCH Venture Partners named to 2025 STATUS List - STAT
-
The biotech venture firm behind Juno and Grail is taking a new approach to tackle mental health - Business Insider
-
New AI drug discovery powerhouse Xaira rises with $1B in funding - Fierce Biotech
-
Synchron Raises $75M Series C Led by ARCH Venture Partners to Advance Endovascular Brain-Computer Interface - businesswire.com
-
Q&A: A biotech VC leader shares her next big bets - STAT
-
Arch raises $1.5B to back early-stage biotechs through accelerating 'healthcare revolution' - Fierce Biotech
-
STATUS List 2024: Kristina Burow, ARCH Venture Partners - STAT
-
Mental health startup focused on seniors launches with $32M, backing from Arch Venture Partners - GeekWire
-
Bob Nelsen on Arch-led megarounds: 'We want the IPO book in the seed round' - Fierce Biotech
-
Recuro Health Closes $47 Million Series B Financing Led by ARCH Venture Partners, Advancing Innovative Virtual-First Care Service - businesswire.com
-
Biotech VC raises $200M to focus on Japan’s ‘untapped source’ of innovation - Fierce Biotech
-
STAT’s 2023 biotech VC rankings show the impact of a volatile market on firms - STAT
-
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences - PR Newswire
-
A top biotech VC and a top tech VC are making a $500 million bet in 2 of the hottest areas of healthcare - Business Insider
-
An Arch-backed biotech raises $53M to fight neurodegeneration - BioPharma Dive
-
ONI Closes $75 Million Series B Led by ARCH Venture Partners and Casdin Capital - businesswire.com
-
Kardigan raises $300m for cardio work, and other financings - pharmaphorum
-
Luna DNA Raises $4 Million Including Key Investors Illumina Ventures and Arch Venture Partners - PR Newswire
-
Arch brings in another $3B for biotech startup investing - BioPharma Dive
-
Arch raises $1.9B to build another crop of breakthrough biotechs - Fierce Biotech
-
ARCH Fuels Up With $3B to Support Next Class of AI Biotechs - BioSpace
-
With $290M in hand, newly emerged biotech Metsera thinks customizable combos are the future of obesity treatments - Fierce Biotech
-
ARCH, biotech’s star slugger, snags another $3B for 13th fund - Endpoints News
-
Meet the 28 startups the biggest investor in biotech is betting on this year - Business Insider
-
New Biopharma Manufacturing Company Founded by Booth Alum Robert Nelsen Raises $800 Million - Polsky Center for Entrepreneurship and Innovation
-
Biotech VC Kristina Burow Details How Arch Venture Creates Startups - Business Insider
-
Arch's Keith Crandell talks Chicago, biotech - Axios
-
Arch, a prolific biotech creator, is raising $3B for startup investing - BioPharma Dive
-
ARCH raises $3bn for biotech innovation - alternativeswatch.com
-
Robert Nelsen's Antiaging Routine As a 60-Year-Old Anti-Aging Investor - Business Insider
-
ARCH Venture Partners Appoints Kent Rogers As Venture Partner - citybiz
-
JW ties up with US venture capitalist for ‘R&D open innovation’ - Korea Biomedical Review
-
ARCH Venture Partners Lead $270 Million Series A For Orbital Therapeutics - citybiz
-
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development - businesswire.com
-
ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs - STAT
-
eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation - SynBioBeta
-
Latest ARCH Venture Partners Fund Closes Above $400 Million - PR Newswire
-
Biotech's top money raisers of 2024 - Fierce Biotech
-
Meet Neumora, Arch's $500M, Amgen-partnered play for the targeted future of neuroscience R&D - Fierce Biotech
-
Daniel Crowley - Irish America
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.